Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-006125
Filing Date
2013-05-15
Accepted
2013-05-15 16:21:12
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q talon_10q-033113.htm 10-Q 1008826
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15737
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16288
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6805
  Complete submission text file 0001437749-13-006125.txt   8588536

Data Files

Seq Description Document Type Size
5 tlon-20130331.xml EX-101.INS 1579979
6 tlon-20130331.xsd EX-101.SCH 72335
7 tlon-20130331_cal.xml EX-101.CAL 28397
8 tlon-20130331_def.xml EX-101.DEF 344997
9 tlon-20130331_lab.xml EX-101.LAB 462333
10 tlon-20130331_pre.xml EX-101.PRE 349488
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32626 | Film No.: 13847427
SIC: 2834 Pharmaceutical Preparations